Revolutionizing Biotech by Turning CO₂ into High-Value Microalgae

Proprietary LED-Photobioreactor Technology · Pharmaceutical Quality · 75–90% Below Market Cost · CO₂-Negative Production

0
Peak Biomass Density
30–70× Industry Standard
0
Upstream Production Cost
75–90% Below Market
0
EBITDA Margin
At Target Capacity
Request Investor Deck Discover Technology ↓
Problem & Solution

The Production Trilemma of the Algae Industry

Existing methods force producers to choose between three desirable properties — but no technology delivers all three simultaneously. Until now.

Quality Cost Scale PHYOX All Three.
⬡

Pharmaceutical Quality

Closed PBR system ensures contamination-free biomass. HPLC analytics, batch traceability, and €600K lab equipment for every production run.

◉

Year-Round Consistency

360 production days/year. LED-controlled, weather-independent. Semi-continuous harvesting with reproducible results across all 11 production lines.

△

€4/kg Production Cost

75–90% below conventional European methods. Break-even at 0.8 g/L — system delivers 2.61 g/L average and 5.45 g/L peak.

Core Technology

Proprietary LED-Photobioreactor System

Closed tubular photobioreactors with proprietary LED illumination — delivering lab-grade results at industrial scale.

144
Closed PBR Units
11
Production Lines
40K L
Total Volume
600 m²
Production Hall
360
Days/Year
100%
Photoautotrophic

Scale-Up Gap: Where PHYOX Breaks Through

Typical industry scale-up loss: 80–95%. PHYOX scale-up loss: ~30%. We deliver lab-grade biomass at industrial volume — a globally unique achievement.

Industry Standard
0.08–2.0 g/L
PHYOX Average
2.61 g/L
PHYOX Peak
5.45 g/L
67/100
Best Overall PBR Score Worldwide Scalability 10/10 · Contamination Protection 10/10 · Light Distribution 9/10
+200% Optimization Potential Untapped: All current data achieved WITHOUT LED supplemental lighting, CO₂ enrichment, or temperature control. Long-term target: 5.0 g/L reproducible average.
Intellectual Property

5 Protected Rights in 2 Patent Families

◈

Closed Flat-Plate Design — contamination protection & precise process control

◈

U-Shaped Flow Path — unique geometry, optimal mixing without mechanical stirrers

◈

CO₂ Integration Claims — direct coupling to biogas/industrial exhaust streams

◈

Modular Construction — scalable from lab to industrial without redesign

◈

Energy Efficiency — natural light optimization through flat-plate geometry

Market Opportunity

A Multi-Billion Market — and We're Ready

150+ validated data points from 5 independent research institutes confirm massive, growing demand for pharmaceutical-grade Chlorella.

TAMGlobal Chlorella
SAMEU B2B + DACH B2C
SOM5yr
TAM — Global Chlorella market (growing at 7.7% CAGR)
SAM — European B2B + DACH B2C Supplements
SOM — Achievable within 5 years

Four Megatrends Driving Demand

🧬

Protein Transition

Global shift toward sustainable, plant-based protein sources with complete amino acid profiles.

💊

Supplement Boom

German NEM market: €3.91B (2026). 70% of Germans use supplements regularly.

🌿

Sustainability Regulation

Increasing EU regulatory pressure for sustainable, traceable production methods.

🌊

Blue Economy Rise

EU Blue Economy Strategy prioritizes bioeconomy, climate protection & food security.

Business Model

Dual-Revenue with 67–80% EBITDA Margins

B2B Bulk Biomass · 60% Revenue
Target Price€55/kg
Upstream Cost€4/kg
Gross Margin~93%
Top Price Driver"Made in EU" (r = 0.82)
CustomersNutra · Cosmetics · Food
B2C Premium Supplements · 40% Revenue
Retail Equiv. Price€184/kg
COGS incl. Packaging€68.47/kg
DTC Gross Margin82.3%
ChannelShopify DTC + Subscription
TargetDACH Health-Conscious 25–55

The PHYOX Flywheel

Scale Production
→
Unit Costs ↓
→
Higher Margins
→
More R&D
→
AI Optimizes Yields
→
More Biomass
→
More Customers
→
More Data
↻

Additional Revenue Streams: Technology Licensing (€50K–200K upfront + 3–6% royalty) · CO₂ Certificates · PHYCION AI SaaS

Financial Projections

Cash-Flow Positive from Month 4

0
5-Year CAGR
0
Year 5 Cash Position
0
Months Cash Runway
0
Validated Formulas

5-Year Revenue Projection

Y1
Ramp-Up
Y2
Growth
Y3
Scale
Y4
Expand
Y5
€19M+ Cash

Use of Funds — €6M Seed Round

Production
R&D
B2C Launch
Working Cap.
Regulatory
Production Scale-Up
R&D & Optimization
B2C Launch & Marketing
Working Capital
Regulatory & Certs
Sustainability & Impact

CO₂-Negative. Water-Efficient. Impact-Driven.

0
CO₂ fixed per kg biomass
0
CO₂ captured at target capacity
0
Water usage (vs. 500–2,000 L open pond)
0
Forest O₂ equivalent from 600 m²
SDG 2 — Zero Hunger
SDG 9 — Innovation
SDG 12 — Responsible Consumption
SDG 13 — Climate Action
SDG 14 — Life Below Water

Aligned with: EU Blue Economy Strategy · EU Bioeconomy Strategy · European Green Deal · Farm-to-Fork Strategy

Leadership

Experienced Founders. Proven Results.

BH
Bernd Herrmann
CEO & Founder
  • 25+ years industrial plant engineering & biotechnology
  • Serial entrepreneur — electrician → project management → biotech founder
  • €6.8M+ personal investment into PHYOX
  • Achieved 5.45 g/L peak — 30–70× industry standard
  • Systematic iteration of dozens of reactor designs over 4 years R&D
"Our 600 m² production releases as much oxygen annually as 40 hectares of forest. That's not just technology — that's impact."
DH
Daniel Huber
CFO & Co-Founder
  • 22+ years business development & startup financing
  • €235M fundraising track record (Miro Forestry, London/Frankfurt)
  • CEO Dexpo.space (since 06/2025), CEO CANVENA Ltd. (since 07/2021)
  • Biotech financial modeling, fundability analysis & investor relations
  • Strategic advisory at EagleStar Consulting

~9.5 FTE current team · Scaling to 14+ planned positions · Remote-team strategy for cost efficiency (€600/person/month)

Production & Location

EU Production. DACH Market. Global Ambition.

Strategic production site in Novska, Croatia — full EU member since 2013 — combining cost advantages with premium market access.

⚑
Full EU Membership

"Made in EU" designation — strongest B2B price driver (r = 0.82). No trade barriers.

⟐
2–5 Day Delivery to DACH

vs. 4–8 weeks from Asia. EU-internal logistics without customs or import restrictions.

☀
200 kWp PV Potential

70% energy self-sufficiency. ~€86,000/year savings. Access to biogas CO₂ sources.

€
€5.2B EU Cohesion Funds

Croatian Investment Promotion Act: Up to €1M grant + 5 years tax exemption.

Funding & Grants

€2.5–4.5M Grant Potential Identified

25+ programs across EU, Croatian, and German/Bavarian funding landscapes — systematically mapped and prioritized.

Stage 1 — Immediate (Mar–Apr 2026)

Croatian Investment Promotion Act · EIC Accelerator (Deadline May 6) · KfW ERP Innovation Credit

Stage 2 — Short-Term (Apr–Sep 2026)

EU Innovation Fund (Apr 23) · CBE JU (Apr–Sep) · BMBF KMU-innovativ (Apr 15)

Stage 3 — Mid-Term (Q3 2026–Q2 2027)

Horizon Europe Cluster 6 · LIFE Programme · Bavarian Future Technologies

Investment Opportunity

€6M Seed Round — Invest Now

Join the next wave of sustainable biotech. PHYOX BioGenesis combines proprietary technology, proven economics, and massive market opportunity.

✓
Proprietary technology with 5 patents in 2 families
✓
30–70× better performance than industry standard at industrial scale
✓
75–90% cost advantage over European competitors
✓
€19M+ projected cash position in Year 5
✓
CO₂-negative, EU-funded, SDG-aligned
✓
Founding team with €235M fundraising track record
Request Investor Deck Contact Us

PHYOX BioGenesis GmbH · invest@phyox.com · phyox.space